Investorsbuzz

Investors discussing news, views and opinions

Investorsbuzz

Archives for September, 2009


Underarm Lotion Boosts Sex Drive

Posted by scienceinvestor on Wednesday, September 30th 2009     

Men with low testosterone levels, which is occuring in more than a third of men over 45, can end up having low sex drive, cause impotentce, memory loss, and osteoporosis according to the Mayo Clinic in Rochester.
This condition could one day be treated simply by applying an underarm Lotion called Axiron, developed by Melbourne based [...]

Read the rest of this entry »

Categorized in Biotech/Pharma, Health Care
Tags: , ,

BioPharma News for the Day

Posted by scienceinvestor on Wednesday, September 30th 2009     

Multiple Sclerosis
Novartis AG (NVS) unveiled positive late stage test results on its experimental Multiple Sclerosis drug which it plans to file for FDA approval by the end of the year. Citi upgraded their recommendation for Novartis shares to buy subsequent to this news. The other MS drug makers Biogen, Elan, Teva Pharma, and Genzyme were [...]

Read the rest of this entry »

Categorized in Biotech/Pharma, Health Care
Tags: , , , , , , , , ,

Sequenom CEO and Research Executive Dismissed

Posted by scienceinvestor on Monday, September 28th 2009     

Here a quick update on the story about Sequenom I wrote about a few months ago: now the CEO and a senior research executive were dismissed after mishandling the results for the development of a test for down syndrom, test data “included inadequately substantiated claims, inconsistencies, and errors,” Sequenom stated today (bloomberg). “Due to the [...]

Read the rest of this entry »

Categorized in Biotech/Pharma, Health Care
Tags:

Johnson and Johnson Going Shopping Again – This Time Crucell

Posted by scienceinvestor on Monday, September 28th 2009     

J&J has bought an 18% stake in Crucell , the Dutch based developer of drugs and flu vaccines, for $440 Mio, which is a premium of 30% to the Friday’s close. The deal enables J&J “access to antibody and vaccine know-how and technology, and expands our ability to offer preventive health care solutions for unmet [...]

Read the rest of this entry »

Categorized in Biotech/Pharma, Health Care
Tags: , ,

Eli Lilly cutting 5500 jobs

Posted by scienceinvestor on Monday, September 14th 2009     

Eli Lilly has anounced today that it will cut around 5500 jobs (13.5% of jobs) as the company’s top line growth decreases due to patent expires and resulting generic competition of top selling drugs by 2011, like schizophrenia drug Zyprexa and cancer treatment Gemzar. Also the Byetta diabetes drug as well as safety concerns for its recently approved [...]

Read the rest of this entry »

Categorized in Biotech/Pharma, Health Care
Tags: , , ,

When will the Monthly Leveraged ETFs be available?

Posted by admin on Thursday, September 10th 2009     

Leveraged ETFs have become extremely popular in the investor community over recent years. They allow investors to take long or short positions in broad sectors and markets with daily returns of two or three times of the underlying index. They do not really borrow money, but use swaps and other derivatives to multiply the movement of the [...]

Read the rest of this entry »

Categorized in Financials, Other
Tags: , , , , ,

DXO closed

Posted by admin on Wednesday, September 2nd 2009     

Looks like the Energy ETF DXO (Double Long Crude ETN) is history. Deutsche Bank confirmed that it will redeem all outstanding PowerShares DB Crude Oil Double Long Exchange Traded notes as a consequence of changing regulatory environment, i.e. resulting from the efforts of the CFTC. Notice of redemption is expected to go out September 9, [...]

Read the rest of this entry »

Categorized in Oil
Tags: